flurbiprofen has been researched along with Lung Neoplasms in 10 studies
Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.
Lung Neoplasms: Tumors or cancer of the LUNG.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Flurbiprofen, indomethacin and other NSAIDs stimulated 15-PGDH activity in colon cancer HT29 cells as well as in lung cancer A549 cells and glioblastoma T98G cells." | 4.87 | Regulation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by non-steroidal anti-inflammatory drugs (NSAIDs). ( Chi, X; Tai, HH; Tong, M, 2011) |
| "In the present study, we have examined the antimetastatic effect of flurbiprofen, a nonsteroidal antiinflammatory drug, on spontaneous metastases formation in mice bearing Lewis lung carcinoma and these results were compared with effects of other inhibitors of platelet function (mopidamole, dipyridamole, pentoxifylline)." | 3.67 | Antimetastatic effect of flurbiprofen and other platelet aggregation inhibitors. ( Grimová, J; Kacerovská, H; Mamytbeková, A; Rezábek, K; Svobodová, J, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (40.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, JC | 2 |
| Chai, XQ | 2 |
| Wang, D | 2 |
| Shu, SH | 1 |
| Magnussen, CG | 1 |
| Xie, LX | 1 |
| Hu, SS | 2 |
| Sakamaki, K | 1 |
| Watanabe, K | 1 |
| Woo, T | 1 |
| Masuda, M | 1 |
| Gao, W | 1 |
| Yang, XL | 1 |
| Gu, H | 1 |
| Wu, XN | 1 |
| Wang, S | 1 |
| Tai, HH | 1 |
| Chi, X | 1 |
| Tong, M | 1 |
| Millar, BC | 1 |
| Chaplin, DJ | 1 |
| Jinks, S | 1 |
| Lokeshwar, BL | 1 |
| Houston-Clark, HL | 1 |
| Selzer, MG | 1 |
| Block, NL | 1 |
| Golub, LM | 1 |
| Wechter, WJ | 1 |
| Leipold, DD | 1 |
| Murray, ED | 1 |
| Quiggle, D | 1 |
| McCracken, JD | 1 |
| Barrios, RS | 1 |
| Greenberg, NM | 1 |
| Murphy, P | 1 |
| Alexander, P | 1 |
| Senior, PV | 1 |
| Fleming, J | 1 |
| Kirkham, N | 1 |
| Taylor, I | 1 |
| Mamytbeková, A | 2 |
| Rezábek, K | 2 |
| Grimová, J | 2 |
| Svobodová, J | 2 |
| Kacerovská, H | 1 |
1 review available for flurbiprofen and Lung Neoplasms
| Article | Year |
|---|---|
Regulation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by non-steroidal anti-inflammatory drugs (NSAIDs).
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line, | 2011 |
3 trials available for flurbiprofen and Lung Neoplasms
| Article | Year |
|---|---|
Intraoperative Flurbiprofen Treatment Alters Immune Checkpoint Expression in Patients Undergoing Elective Thoracoscopic Resection of Lung Cancer.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; China; Elective Surgical Procedures; Emulsions | 2020 |
Multicentre randomised phase II study of the perioperative administration of flurbiprofen axetil in patients with non-small cell lung cancer: study protocol of the FLAX Study.
Topics: Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase II as Topic; Flurbiprofen; Humans; Japan; Lun | 2020 |
Continuous Serratus Anterior Plane Block Improved Early Pulmonary Function After Lung Cancer Surgical Procedure.
Topics: Adolescent; Adult; Aged; Analgesics; Female; Flurbiprofen; Follow-Up Studies; Forced Expiratory Volu | 2022 |
6 other studies available for flurbiprofen and Lung Neoplasms
| Article | Year |
|---|---|
Studies on the protection against misonidazole-induced toxicity by antiinflammatory agents.
Topics: Animals; Cell Line; Cell Survival; Cricetinae; Cricetulus; Dexamethasone; Female; Flurbiprofen; Lung | 1983 |
Potential application of a chemically modified non-antimicrobial tetracycline (CMT-3) against metastatic prostate cancer.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cell Division; D | 1998 |
E-7869 (R-flurbiprofen) inhibits progression of prostate cancer in the TRAMP mouse.
Topics: Adenocarcinoma; Animals; Body Weight; Dietary Fats; Disease Models, Animal; Disease Progression; Flu | 2000 |
Mechanisms of organ selective tumour growth by bloodborne cancer cells.
Topics: Animals; Carcinogens; Cardiac Output; Cyclosporins; Dexamethasone; Female; Flurbiprofen; Injections, | 1988 |
Inhibitory action of flurbiprofen and mopidamole on tumor lung metastasis formation in mice.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Flurbiprofen; Lung Ne | 1987 |
Antimetastatic effect of flurbiprofen and other platelet aggregation inhibitors.
Topics: Animals; Antineoplastic Agents; Dipyridamole; Flurbiprofen; Lung Neoplasms; Male; Mice; Mice, Inbred | 1986 |